Bone Marrow derived Cell Therapy in Critical Limb Ischemia: A Meta-analysis of Randomized Placebo Controlled Trials

European Journal of Vascular and Endovascular Surgery

Volumn 50, Issue 6, 2015, Pages 775-783

  Peeters Weem, S M O ^a   Teraa, M ^a   De Borst, G J ^a   Verhaar, M C ^a   Moll, F L ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Bone marrow derived cell therapy; Cell therapy; CLI; Critical limb ischemia; Meta analysis; Peripheral arterial disease

Indexed keywords

PLACEBO;

AMPUTATION; ANKLE BRACHIAL INDEX; BIBLIOGRAPHIC DATABASE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CRITICAL LIMB ISCHEMIA; FOLLOW UP; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; META ANALYSIS; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SURVIVAL; SYSTEMATIC REVIEW; TRANSCUTANEOUS OXYGEN MONITORING; ULCER HEALING; ADULT; ADVERSE EFFECTS; AGED; BONE MARROW TRANSPLANTATION; CHI SQUARE DISTRIBUTION; CRITICAL ILLNESS; DISEASE FREE SURVIVAL; ISCHEMIA; LIMB SALVAGE; MIDDLE AGED; MORTALITY; ODDS RATIO; PATHOPHYSIOLOGY; PERIPHERAL ARTERIAL DISEASE; REOPERATION; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AMPUTATION; BONE MARROW TRANSPLANTATION; CHI-SQUARE DISTRIBUTION; CRITICAL ILLNESS; DISEASE-FREE SURVIVAL; HUMANS; ISCHEMIA; LIMB SALVAGE; MIDDLE AGED; ODDS RATIO; PERIPHERAL ARTERIAL DISEASE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REOPERATION; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84944111918     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2015.08.018     Document Type: Review

References (39)

1. L. Norgren, W.R. Hiatt, J.A. Dormandy, M.R. Nehler, K.A. Harris, and F.G.R. Fowkes Inter-society consensus for the management of peripheral arterial disease (TASC II) J Vasc Surg 45 Suppl. 2007 S5 S67
2. R.W. Sprengers, M. Teraa, F.L. Moll, G.A. de Wit, Y. van der Graaf, and M.C. Verhaar Quality of life in patients with no-option critical limb ischemia underlines the need for new effective treatment J Vasc Surg 52 2010 843 849
3. E. Benoit, T.F. O'Donnell, M.D. Iafrati, E. Asher, D.F. Bandyk, J.W. Hallett, and et al. The role of amputation as an outcome measure in cellular therapy for critical limb ischemia: implications for clinical trial design J Transl Med 9 2011 165
4. E. Tateishi-Yuyama, H. Matsubara, T. Murohara, U. Ikeda, S. Shintani, H. Masaki, and et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial Lancet 360 2002 427 435
5. P. Barc, J. Skóra, A. Pupka, D. Turkiewicz, A.T. Dorobisz, J. Garcarek, and et al. Bone-marrow cells in therapy of critical limb ischaemia of lower extremities - own experience Acta Angiol 12 2006 155 166
6. N.R. Dash, S.N. Dash, P. Routray, S. Mohapatra, and P.C. Mohapatra Targeting nonhealing ulcers of lower extremity in human through autologous bone marrow-derived mesenchymal stem cells Rejuvenation Res 12 2009 359 366
7. M. Teraa, R.W. Sprengers, Y. van der Graaf, C.E.J. Peters, F.L. Moll, and M.C. Verhaar Autologous bone marrow-derived cell therapy in patients with critical limb ischemia: a meta-analysis of randomized controlled clinical trials Ann Surg 258 2013 922 929
8. M. Li, H. Zhou, X. Jin, M. Wang, S. Zhang, and L. Xu Autologous bone marrow mononuclear cells transplant in patients with critical leg ischemia: preliminary clinical results Exp Clin Transpl 11 2013 435 439
9. P.K. Gupta, A. Chullikana, R. Parakh, S. Desai, A. Das, S. Gottipamula, and et al. A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia J Transl Med 11 2013 143
10. A.N. Raval, E.G. Schmuck, G. Tefera, C. Leitzke, Ark C. Vander, D. Hei, and et al. Bilateral administration of autologous CD133+ cells in ambulatory patients with refractory critical limb ischemia: lessons learned from a pilot randomized, double blind, placebo controlled trial Cytotherapy 16 2014 1720 1732
11. M. Teraa, R.W. Sprengers, R.E.G. Schutgens, I.C.M. Slaper-Cortenbach, Y. van der Graaf, A. Algra, and et al. Effect of repetitive intra-arterial infusion of bone marrow mononuclear cells in patients with no-option limb ischemia: the randomized, double blind, placebo controlled JUVENTAS Trial Circulation 131 2015 851 860
12. D.W. Losordo, M.R. Kibbe, F. Mendelsohn, W. Marston, V.R. Driver, M. Sharafuddin, and et al. A randomized, controlled pilot study of autologous CD34+ cell therapy for critical limb ischemia Circ Cardiovasc Interv 5 2012 821 830
13. K.F. Schulz, D.G. Altman, and D. Moher CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials Open Med 4 2010 E60 E68
14. G. Guyatt, A.D. Oxman, E.A. Akl, R. Kunz, G. Vist, J. Brozek, and et al. GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables J Clin Epidemiol 64 2011 383 394
15. Fedorov S. Get data graph digitizer. Available at: http://www.getdata-graph-digitizer.com (accessed 07.09.15).
16. S.P. Hozo, B. Djulbegovic, and I. Hozo Estimating the mean and variance from the median, range, and the size of a sample BMC Med Res Methodol 5 2005 13
17. A. Schiavetta, C. Maione, C. Botti, G. Marino, S. Lillo, A. Garrone, and et al. A phase II trial of autologous transplantation of bone marrow stem cells for critical limb ischemia: results of the Naples and Pietra Ligure evaluation of stem cells study Stem Cells Transl Med 1 2012 572 578
18. A. Klepanec, M. Mistrik, C. Altaner, M. Valachovicova, I. Olejarova, R. Slysko, and et al. No difference in intra-arterial and intramuscular delivery of autologous bone marrow cells in patients with advanced critical limb ischemia Cell Transpl 21 2012 1909 1918
19. S. Kirana, B. Stratmann, C. Prante, W. Prohaska, H. Koerperich, D. Lammers, and et al. Autologous stem cell therapy in the treatment of limb ischaemia induced chronic tissue ulcers of diabetic foot patients Int J Clin Pract 66 2012 384 393
20. M. Kinoshita, Y. Fujita, M. Katayama, R. Baba, M. Shibakawa, K. Yoshikawa, and et al. Long-term clinical outcome after intramuscular transplantation of granulocyte colony stimulating factor-mobilized CD34 positive cells in patients with critical limb ischemia Atherosclerosis 224 2012 440 445
21. Z. Dong, B. Chen, W. Fu, Y. Wang, D. Guo, Z. Wei, and et al. Transplantation of purified CD34+ cells in the treatment of critical limb ischemia J Vasc Surg 58 2013 404 411 e3
22. Y. Fujita, M. Kinoshita, Y. Furukawa, T. Nagano, H. Hashimoto, Y. Hirami, and et al. Phase II clinical trial of CD34+ cell therapy to explore endpoint selection and timing in patients with critical limb ischemia Circ J 78 2014 490 501
23. N.M. Malyar, S. Radtke, K. Malyar, J. Arjumand, P.A. Horn, K. Kröger, and et al. Autologous bone marrow mononuclear cell therapy improves symptoms in patients with end-stage peripheral arterial disease and reduces inflammation-associated parameters Cytotherapy 16 2014 1270 1279
24. M. Arai, Y. Misao, H. Nagai, M. Kawasaki, K. Nagashima, K. Suzuki, and et al. Granulocyte colony-stimulating factor: a noninvasive regeneration therapy for treating atherosclerotic peripheral arterial disease Circ J 70 2006 1093 1098
25. L. Debin, J. Youzhao, L. Ziwen, L. Xiaoyan, Z. Zhonghui, and C. Bing Autologous transplantation of bone marrow mesenchymal stem cells on diabetic patients with lower limb ischemia J Med Coll PLA 23 2008 106 115
26. P. Huang, S. Li, M. Han, Z. Xiao, R. Yang, and Z. Han Autologous transplantation of granulocyte colony-stimulating factor - mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes Diabetes Care 28 9 2005 2155
27. A. Ozturk, Y. Kucukardali, F. Tangi, A. Erikci, G. Uzun, C. Bashekim, and et al. Therapeutical potential of autologous peripheral blood mononuclear cell transplantation in patients with type 2 diabetic critical limb ischemia J Diabetes Complications 26 2012 29 33
28. V. Procházka, J. Gumulec, F. Jalůvka, D. Salounová, T. Jonszta, D. Czerný, and et al. Cell therapy, a new standard in management of chronic critical limb ischemia and foot ulcer Cell Transpl 19 2010 1413 1424
29. G.V. Szabó, Z. Kövesd, J. Cserepes, J. Daróczy, M. Belkin, and G. Acsády Peripheral blood-derived autologous stem cell therapy for the treatment of patients with late-stage peripheral artery disease-results of the short- and long-term follow up Cytotherapy 15 2013 1245 1252
30. X. Wang, L. Jiang, X. Wang, F. Yin, G. Li, X. Feng, and et al. Combination of autologous transplantation of G-CSF-mobilized peripheral blood mononuclear cells and Panax notoginseng saponins in the treatment of unreconstructable critical limb ischemia Ann Vasc Surg 28 2014 1501 1512
31. G.P. Lasala, J.A. Silva, and J.J. Minguell Therapeutic angiogenesis in patients with severe limb ischemia by transplantation of a combination stem cell product J Thorac Cardiovasc Surg 144 2012 377 382
32. B. De Angelis, P. Gentile, F. Orlandi, I. Bocchini, C. Di Pasquali, A. Agovino, and et al. Limb rescue: a new autologous-peripheral blood mononuclear cells technology in critical limb ischemia and chronic ulcers Tissue Eng Part C Methods 21 2015 423 435
33. D.H. Walter, H. Krankenberg, J.O. Balzer, C. Kalka, I. Baumgartner, M. Schlüter, and et al. Intra-arterial administration of bone marrow mononuclear cells in patients with critical limb ischemia: a randomized-start, placebo controlled pilot trial (PROVASA) Circ Cardiovasc Interv 4 2011 26 37
34. R.J. Powell, W.A. Marston, S.A. Berceli, R. Guzman, T.D. Henry, A.T. Longcore, and et al. Cellular therapy with Ixmyelocel-T to treat critical limb ischemia: the randomized, double blind, placebo controlled RESTORE-CLI trial Mol Ther 20 2012 1280 1286
35. D. Lu, B. Chen, Z. Liang, W. Deng, Y. Jiang, S. Li, and et al. Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double blind, randomized, controlled trial Diabetes Res Clin Pract 92 2011 26 36
36. M. Teraa, R.W. Sprengers, P.E. Westerweel, H. Gremmels, M.-J.T.H. Goumans, T. Teerlink, and et al. Bone marrow alterations and lower endothelial progenitor cell numbers in critical limb ischemia patients PLoS One 8 2013 e55592
37. H. Gremmels, M. Teraa, P.H. Quax, K. den Ouden, J.O. Fledderus, and M.C. Verhaar Neovascularization capacity of mesenchymal stromal cells from critical limb ischemia patients is equivalent to healthy controls Mol Ther 22 2014 1960 1970
38. H. Gremmels, J.O. Fledderus, M. Teraa, and M.C. Verhaar Mesenchymal stromal cells for the treatment of critical limb ischemia: context and perspective Stem Cell Res Ther 4 2013 1
39. T. Kinnaird, E.S. Burnett, M. Shou, C.W. Lee, S. Barr, S. Fuchs, and et al. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms Circulation 109 2004 1543 1549